Trial Profile
A open-label, single-sequence, 3-period, crossover study to evaluate the pharmacokinetic drug–drug interactions of drug when LCZ696 was coadministered with hydrochlorothiazide in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Hydrochlorothiazide
- Indications Heart failure
- Focus Pharmacokinetics
- Acronyms LCZ696/HCTZ DDI study
- 11 Feb 2016 New trial record